Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cholesterol: Significance and Regulation
Overview of Lipid Metabolism
Lipid Catabolism
Cardiomyopathy II: Dilated Cardiomyopathy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 19, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Abdelwahab Jalal Eldin1, Baris Akinci1,2, Andre Monteiro da Rocha3
1Division of Metabolism, Endocrinology and Diabetes (MEND), Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
Familial partial lipodystrophy (FPLD) patients with LMNA variants face higher cardiac risks, particularly arrhythmias. Studying laminopathy in FPLD using patient-derived cells reveals disease mechanisms and informs monitoring strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: